Drawing for CLOO 9

USPTO serial 79430829

CLOO 9

Reviewed by CopyMark Law Group

Status 649Office Action
Filing date
Status date
Registration date
Examiner
CORNWELL, ANDREA B
Law office
TMO LAW OFFICE 115

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with CLOO 9?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely pharmaceutical preparations for skin care; medicinal products, namely, medicinal drinks, tablets, capsules, powders, jellies, granules, lozenges, pastilles, syrups, suspensions, emulsions, solutions and drops, all for Gastrointestinal health, Metabolic and weight management, Cardiovascular health, Immune system support, Skin, hair, and beauty, Detoxification and liver health, Hormonal and endocrine health, Brain and mental health, Musculoskeletal health, Energy and fatigue, Respiratory health, Reproductive and sexual health, Eye health, Anti-aging and longevity and General wellness; veterinary products, namely veterinary vaccines; infants' foods and dietetic foods adapted for sick persons for medical purposes; nutritional supplements including food supplements, collagens and enzymes; food supplements; dietary supplements; vitamins, mineral preparations, and mineral salts for medical purposes; preparations consisting of vitamins and/or minerals for medical purposes; collagen for medical purposes; collagen dietary supplements; enzymes for medical purposes; enzyme dietary supplements; medicinal herbs; herbal preparations for medical use; herbal supplement preparations being nutritional supplements; oils and fat being nutritional supplements; oil-based and fat-based nutritional supplements; oils and fats for medical purposes and derivatives of oils and fats for medical dietary supplementation purposes namely, vitamin oils, almond oils, camphor oils, castor oils, linseed oils, mustard oils, all for human consumption, and medicinal oils, other than essential oils; fish oils, including cod liver oil, as nutritional supplements; laxatives; protein supplements, and ginseng, being for medicinal purposes; nutritional supplements.ACTIVE
029Edible oils and edible fats, namely, almond oil, coconut oil, linseed oil, corn oil, olive oil, palm oil, rape oil, sesame oil, sunflower oil, soya bean oil; protein-based products, namely, formed textured vegetable protein for use as a meat substitute, high-protein snack bars, namely nut-based snack bars, seed-based snack bars, fruit-based snack bars, oat-based snack bars, cereal-based snack bars, granola-based snack bars, coconut-based snack bars, honey-based snack bars, dairy-based snack bars, milk protein-based snack bars, whey protein-based snack bars, casein protein-based snack bars and egg protein-based snack bars.ACTIVE
035Online and in-store wholesale and retail store services featuring pharmaceutical, medicinal and veterinary products, foods for infants' and sick persons, nutritional supplements, vitamins, mineral preparations and mineral salts for medical purposes, preparations consisting of vitamins and/or minerals, medicinal herbs, herbal preparations, oils and fats and derivatives of oils and fats, fish oils including cod liver oil, laxatives, protein, ginseng, being for medicinal purposes, edible oils and edible fats, their derivatives and products derived therefrom, nutritional supplements, preparations derived from foodstuffs being food supplements, protein shakes, protein powders, protein bars, protein cookies, protein smoothies, protein-infused water, protein pudding, foodstuffs derived from cereals, ginseng, not medicinal, nutritional bars and powders.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 11, 2026RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
May 11, 2026RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
May 11, 2026RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Apr 9, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 18, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Mar 18, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 18, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2025RFNTREFUSAL PROCESSED BY IB
Oct 20, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 20, 2025RFRRREFUSAL PROCESSED BY MPU
Sep 4, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2025DOCKASSIGNED TO EXAMINER
Aug 25, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Aug 25, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance